Astellas Spatial Biology Seminar

In-Person Seminar, Virtual Seminar
Astellas, Suite 310, Room 326, 1030 Massachusetts Ave., Cambridge, MA 02138Link

Why You Should Use Spatial Biology Tools to Improve Biomarker Discovery in Drug Development

Join us in person or virtually for an exciting seminar. Spatial biology is revolutionizing the way we understand cellular organization and its impact on disease progression. By combining cutting-edge technologies like the GeoMx® Digital Spatial Profiler (DSP) and CosMx™ Spatial Molecular Imager (SMI) researchers can unlock vital insights into cellular interactions, molecular pathways, and biomarker localization, all within the context of intact tissue samples.

Our distinguished speaker, Espy Anguiano, will share her expertise and real-world examples of how these innovative technologies have propelled scientific breakthroughs. Benefit from her practical tips for experimental design, optimizing research workflows, and data analysis.

Key highlights of the seminar

  • Dive into the basics of spatial biology and its relevance to drug development
  • Learn how spatial biology accelerates target identification and validation
  • Explore real-world case studies showcasing successful integration of spatial biology tools in drug development
  • Gain expert insights on best practices and tips for data analysis in spatial biology studies

Registration for this event is now closed.


Espy Anguiano, PhD, MS-MBA

Scientific Market Development Director for Biopharma, NanoString

Dr. Espy Anguiano, Scientific Market Development Director at NanoString, obtained her PhD in Biomedical Science from Baylor University and holds a dual MBA degree from Temple University. She has over 20 years of experience in translational and clinical biomarker research in both academic and industry settings. Dr. Anguiano is a biomarker technology subject matter expert and has led biomarker and biomarker technology strategies for many early- and late-phase clinical trials in oncology and non-oncology disease areas. In her current role at NanoString, she is responsible for enabling the successful adoption of bulk and spatial technologies in research activities supporting drug discovery and development.